NCT01458327View on ClinicalTrials.gov

Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

December 15, 2010

Primary Completion Date

June 27, 2014

Study Completion Date

June 27, 2014

Conditions

Posttraumatic Stress Disorder

Interventions

DRUG

Midomafetamine

125 mg MDMA followed by 62.5 mg MDMA 1.5 to 2.5 hours later

BEHAVIORAL

Therapy

Non-directive therapy

Trial Locations (1)

29464

Offices of Michael Mithoefer, Mt. Pleasant

Sponsors

Lead Sponsor

Lykos Therapeutics

All Listed Sponsors

lead

Lykos Therapeutics

INDUSTRY